In 2023, the business enterprise R&D expenditure in human health and social work activities in the US stood at approximately $3.37 billion (PPP = 2015). The forecasted data for the period from 2024 to 2028 shows a consistent upward trend, indicating a strong growth trajectory, beginning at $3.94 billion in 2024 and reaching $6.27 billion by 2028. Year-on-year percentage increases suggest robust expansion with marked annual growth, highlighting significant investment in R&D. The Compound Annual Growth Rate (CAGR) over the five years is substantial, reflecting a healthy average annual growth rate.

Future trends to watch for include:

Technological advancements in healthcare and social work driving increased R&D investments.
Policy changes and governmental incentives influencing spending patterns.
The impact of economic conditions on funding availability and priorities.